Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

ChemoCentryx Inc. (CCXI)

12.82 -0.09 (-0.7%)

09-24 16:00

Open:

12.91

Pre. Close:

12.91

High:

13.15

Low:

12.6942

Volume:

205,738

Market Cap:

646M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

13.161 - 13.227

13.227 - 13.27

Low:

12.533 - 12.62

12.62 - 12.676

Close:

12.694 - 12.827

12.827 - 12.911

Technical analysis  (as of: 2018-09-24 4:37:51 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 15.77     One year: 18.42

Support:

Support1: 11.55    Support2: 10.34

Resistance:

Resistance1: 13.50    Resistance2: 15.77

Pivot:

11.79

Moving Averages:

MA(5): 12.29     MA(20): 11.98

MA(100): 12.10     MA(250): 10.23

MACD:

MACD(12,26): 0.11     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 74.68     %D(3): 62.83

RSI:

RSI(14): 59.44

52-Week:

High: 15.08  Low: 5.42  Change(%): 78.1

Average Vol(K):

3-Month: 18861  10-Days 22662

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CCXI has closed below upper band by 20.8%. Bollinger Bands are 53.9% wider than normal. The large width of the bands suggest high volatility as compared to CCXI's normal range. The bands have been in this wide range for 15 bars. This is a sign that the current trend might continue.

Headline News

2018-09-24T12:01:34-04:00
Aurinia And Voclosporin: Making A Difference In Focal Segmental Glomerulosclerosis

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

50.38

Shares Float (M)

47.51

% Held by Insiders

% Held by Institutions

49.30

Shares Short (K)

2527

Shares Short Prior Month (K)

Stock Financials

EPS

0.340

EPS Est. Current Year

-0.900

EPS Est. Next Year

-1.360

EPS Est. Next Quarter

-0.320

Forward EPS

-0.790

Book Value (p.s.)

21.560

PEG Ratio

Profit Margin

19.06

Operating Margin

16.73

Return on Assets (ttm)

9.6

Return on Equity (ttm)

47.5

Qtrly Rev. Growth

68.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.135

Qtrly Earnings Growth

Operating Cash Flow (M)

42.18

Levered Free Cash Flow (M)

41.29

Valuation

P/E

37.71

P/E Growth Ratio

-0.01

P/BV

0.59

P/S

351017152.00

P/CF

15.31

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.